会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • ENGINEERED BETA-GLUCOSIDASES AND METHODS OF USE THEREOF
    • 工程化β-葡糖苷酶及其使用方法
    • WO2017147690A1
    • 2017-09-08
    • PCT/CA2017/050219
    • 2017-02-22
    • VALORBEC SOCIÉTÉ EN COMMANDITE
    • MARTIN, VincentLARUE, Kane
    • C12N9/42C12N15/56C12N9/24C12P19/02C12P19/14C12P7/10
    • C12P19/14C12N9/2402C12P7/10C12P19/02Y02E50/16
    • A glycoside hydrolase family 3 (GH3) beta-glucosidase (BGL) polypeptide, comprising: (a) a GH3 BGL triosephosphateisomerase domain comprising a sequence as set forth in KGY 1 Y 2 Y 3 Y 4 LGP (SEQ ID NO: 251); (b) a GH3 BGL coordinating loop domain comprising a sequence as set forth in: GLDMX 1 MPX 2 X 3 X 4 X 5 X 6 X 7 X 8 X 9 X 19 X 11 X 12 X 13 X 14 X 15 X 16 (SEQ ID NO: 252), except that at least one of X 1t o X 16 , when present, is smaller than a corresponding reference amino acid residue in a corresponding GH3 BGL reference coordinating loop domain comprising a sequence as set forth in GLDMX 1ref MPX 2ref X 3ref X 4ref X 5ref X 6ref X 7ref X 8ref X 9ref X 19ref X 11ref X 12ref X 13ref X 14ref X 15ref X 16ref (SEQ ID NO: 252); (c) a GH3 BGL β/α sandwich domain comprising a sequence as set forth in: Z 1 Z 2 Z 3 Z 4 Z 5 Z 6 (SEQ ID NO: 253); and/or (d) a GH3 BGL β/α sandwich domain comprising a sequence as set forth in: A 1 A 2 A 3 A 4 A 5 (SEQ ID NO: 254) and a sequence as set forth in B 1 B 2 B 3 B 4 B 5 (SEQ ID NO: 255), with the proviso that the GH3 BGL polypeptide is not a polypeptide as set forth in any one of sequences of SEQ ID NOs: 22 to 44, and is not a secreted form of the polypeptide of any one of SEQ ID NOs: 22 to 44. The GH3 BGL has an improved resistance to substrate inhibition and/or product inhibition. It may be used in methods of converting biomass into a fermentable sugar.
    • 阿糖苷水解酶家族3(GH3)β-葡糖苷酶(BGL)多肽,其包含:(a)一种GH3 BGL磷酸丙糖异构酶结构域包括序列如KGY阐述<子> 1 (SEQ ID NO:251); YYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYYY (b)包含如下所示序列的GH3 BGL协调环结构域:GLDMX 1 MPX 2×3×4×4, /子> X <子> 5 X <子> 6 X <子> 7 X <子> 8 X <子> 9 X < 子> 19 X <子> 11 X <子> 12 X <子> 13 X <子> 14 X <子> 15 阐述的序列环结构域在对应的GH3 BGL参考相应的参考氨基酸残基1ref MPX <子> 2ref X <子> 3ref X <子> 4ref X <子> 5ref X <子> 6ref X <子> 7ref X <子> 8ref X <子> 9ref X <子> 19ref X <子> 11ref X <子> 12ref X <子> 13ref X <子> 14ref X (参见SEQ ID NO:252);以及SEQ ID NO:252。 (c)GH3 BGLβ/α夹心结构域,其包含如以下所示的序列:Z1ZZ2Z3ZZ, (SEQ ID NO:253); SEQ ID NO:53(SEQ ID NO:53); SEQ.ID NO: 和/或(d)包含如下所示序列的GH3 BGLβ/α夹心结构域:A 2 3A 3 (SEQ ID NO:254)和如在B 1 B 2 B B中所示的序列 (SEQ ID NO:255),条件是GH3 BGL多肽不是如在 SEQ ID NO:22至44的序列中的任何一个,并且不是SEQ ID NO:22至44中任一个的多肽的分泌形式.GH3BGL对底物抑制和/或产物抑制具有改善的抗性。 它可以用于将生物质转化为可发酵糖的方法。